Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Cheyne Capital Management (UK) LLP

Q2 2023 · 13F-HR

Cheyne Capital Management (UK) LLPholdings as filed

Filed 2023-07-14 · accession 0000945621-23-000355

$27.1M
Reported value
19
Positions
2023-06-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
532457108LLYLILLY ELI & CO$7.0M25.9%14,960CommonSOLE
674599105OXYOCCIDENTAL PETE CORP$3.1M11.6%53,500CommonSOLE
81141R100SESEA LTD$2.8M10.4%48,800CommonSOLE
81730H109SSENTINELONE INC$2.2M8.24%148,000CommonSOLE
30744W107FTCHQFARFETCH LTD$2.2M8.01%359,907CommonSOLE
867224107SUSUNCOR ENERGY INC NEW$1.4M5.00%46,300CommonSOLE
G65431127NENOBLE CORP PLC$1.3M4.89%32,100CommonSOLE
46266C105IQVIQVIA HLDGS INC$1.1M3.98%4,800CommonSOLE
49456B101KMIKINDER MORGAN INC DEL$1.0M3.81%60,000CommonSOLE
464286400EWZISHARES INC$891,8253.29%27,500CommonSOLE
90353T100UBERUBER TECHNOLOGIES INC$863,4003.18%20,000CommonSOLE
674599162OXY/WSOCCIDENTAL PETE CORP$578,4602.13%15,500CommonNONE
50540R409LSILABORATORY CORP AMER HLDGS$530,9261.96%2,200CommonSOLE
501044101KRKROGER CO$517,0001.91%11,000CommonSOLE
81141RAF7SEALTD 2.375 12/01/25SEA LTD$510,3061.88%500,000CommonNONE
697900108PAASPAN AMERN SILVER CORP$449,0641.65%30,800CommonSOLE
75382E109RAPT THERAPEUTICS INC$374,0001.38%20,000CommonSOLE
934423104WBDWARNER BROS DISCOVERY INC$188,1000.69%15,000CommonSOLE
55910K108MAGENTA THERAPEUTICS INC$35,7550.13%47,170CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.